10 Stocks With At Least $20 Million In Insider Spending Recently

5. Metsera, Inc. (NASDAQ:MTSR)

Highest Individual Purchase: $25,780,032.00

Number of Purchases Worth Between $20 million and $35 million: 2

Market Capitalization: $2.94 billion

In the middle of the list of 10 stocks with at least $20 million in insider spending recently is a New York City-based clinical-stage biotechnology company, Metsera. The company is focused on developing injectable and oral nutrient-stimulated hormone analog peptides to treat obesity and metabolic diseases. It has a broad portfolio of therapies with the potential to address various therapeutic targets and meet the requirements of the weight loss treatment industry. It was founded in 2022 by Population Health Partners and ARCH Venture Partners.

The company went public in February, raising $257 million, pricing shares above its targeted range. During the IPO, two investors acquired $25.78 million worth of Metsera shares each, at a price of $18 per share. Currently, the stock is trading at $28.50 per share, having gained 7.55% since the IPO.

In January, the company shared encouraging results from a 12-week Phase 2a clinical trial of its primary candidate, MET-097i, a potential once-monthly injectable treatment for obesity. The data showed that MET-097i helped participants lose weight, with some shedding up to 20% of their body weight, and it was well tolerated with only mild side effects. The company intends to conduct additional studies in 2025.

Considering this is a stock that recently went public, analyst coverage is, so far, limited.

Metsera is also one of the 10 stocks insiders spent the most money on recently.